These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31343365)

  • 1. The current status of the Transthyretin Amyloidosis Outcomes Survey (THAOS) in Japan.
    Sekijima Y; Mundayat R; Ishii T; Ando Y
    Amyloid; 2019; 26(sup1):61-62. PubMed ID: 31343365
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
    Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
    J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ala97Ser mutation is common among ethnic Chinese Malaysians with transthyretin familial amyloid polyneuropathy.
    Low SC; Tan CY; Md Sari NA; Ahmad-Annuar A; Wong KT; Lin KP; Shahrizaila N; Tan CT; Goh KJ
    Amyloid; 2019; 26(sup1):7-8. PubMed ID: 31343308
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant.
    Nakano Y; Tadokoro K; Ohta Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Yamashita T; Ando Y; Abe K
    J Neurol Sci; 2018 Jul; 390():22-25. PubMed ID: 29801893
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases.
    Cruz MW; Schmidt H; Botteman MF; Carter JA; Chopra AS; Stewart M; Hopps M; Fallet S; Amass L
    Amyloid; 2017 Mar; 24(sup1):109-110. PubMed ID: 28434345
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
    Ikeda S; Nakazato M; Ando Y; Sobue G
    Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac involvement in a large cohort of patients with Val30Met transthyretin amyloidosis from Majorca focus.
    Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
    Amyloid; 2019; 26(sup1):15-16. PubMed ID: 31343338
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
    Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
    Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
    [No Abstract]   [Full Text] [Related]  

  • 10. Geographic distribution of ATTR cases from CEPARM across the Brazilian territory and their clinical aspects, demographics, ethnical and family background.
    Waddington-Cruz M; Pinto MV; Foguel D
    Amyloid; 2019; 26(sup1):53-54. PubMed ID: 31343314
    [No Abstract]   [Full Text] [Related]  

  • 11. The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition.
    Wixner J; Westermark P; Ihse E; Pilebro B; Lundgren HE; Anan I
    Amyloid; 2019; 26(sup1):39-40. PubMed ID: 31343354
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
    Caponetti AG; Rapezzi C; Gagliardi C; Milandri A; Dispenzieri A; Kristen AV; Wixner J; Maurer MS; Garcia-Pavia P; Tournev I; Planté-Bordeneuve V; Chapman D; Amass L;
    JACC Heart Fail; 2021 Oct; 9(10):736-746. PubMed ID: 34391735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
    [No Abstract]   [Full Text] [Related]  

  • 14. Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation.
    Salihoglu A; Yildirim S; Ar MC; Hancer VS; Bozcan S; Yilmaz U; Serin N; Tuzuner N; Celik AF
    Amyloid; 2019; 26(sup1):75-76. PubMed ID: 31343303
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculoleptomeningeal Amyloidosis Due to Transthyretin p.Y89H (Y69H) Variant.
    Quintanilha GS; Cruz MW; Silva MTT; Chimelli L
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1134-1136. PubMed ID: 32856080
    [No Abstract]   [Full Text] [Related]  

  • 17. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L; Coelho T; Dispenzieri A; Conceição I; Waddington-Cruz M; Kristen A; Wixner J; Diemberger I; Gonzalez-Moreno J; Cariou E; Maurer MS; Planté-Bordeneuve V; Garcia-Pavia P; Tournev I; Gonzalez-Costello J; Duarte AG; Grogan M; Mazzeo A; Chapman D; Gupta P; Glass O; Amass L;
    Orphanet J Rare Dis; 2023 Nov; 18(1):350. PubMed ID: 37946256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review.
    Yin J; Xia X; Shi Y; Lu Y; Zhao C; Huang Z; Tian N
    Amyloid; 2014 Jun; 21(2):140-2. PubMed ID: 24601824
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
    Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
    J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The demographic, genetic, and clinical characteristics of Latin American subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey.
    Cruz MW; Barroso F; González-Duarte A; Mundayat R; Ong ML;
    Amyloid; 2017 Mar; 24(sup1):107-108. PubMed ID: 28434322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.